LISA FREYOU: Open Payments
NPI 1154506145 · NEW IBERIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 40 payments from 18 companies in 2025. Trend: 2023 $1,186 · 2024 $2,790 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $115 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| AstraZeneca Pharmaceuticals LP | 1 | $103 |
| Merck Sharp & Dohme LLC | 4 | $59 |
| ABIOMED | 3 | $58 |
| Novo Nordisk Inc | 3 | $48 |
| Boston Scientific Corporation | 2 | $41 |
| PFIZER INC. | 2 | $41 |
| AtriCure, Inc. | 2 | $41 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $40 |
Products named: REPATHA, LEQVIO, LOKELMA, VERQUVO, ELIQUIS, SYNERGY ABLATION SYSTEM, LifeVest, INSPIRE.
Industry payments across LA — which companies pay providers there.
